0001104659-19-002754.txt : 20190122 0001104659-19-002754.hdr.sgml : 20190122 20190122165304 ACCESSION NUMBER: 0001104659-19-002754 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190122 DATE AS OF CHANGE: 20190122 EFFECTIVENESS DATE: 20190122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 19535802 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 12-31-2018 12-31-2018 false Versant Venture Management, LLC

One Sansome Street, Suite 3630 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 N Robin L. Praeger 415-801-8100 Robin L. Praeger San Francisco CA 01-21-2019 0 10 202020918 false INFORMATION TABLE 2 a19-3245_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 1829316 101855 SH OTR 0 101855 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 8536555 1084696 SH OTR 0 1084696 0 Achaogen, Inc. Common Stock 004449104 1575817 1281152 SH OTR 0 1281152 0 Second Sight Medical Products, Inc. Common Stock 81362J100 3978529 4492975 SH OTR 0 4492975 0 Ocular Therapeutix, Inc. Common Stock 67576A100 8817228 2215384 SH OTR 0 2215384 0 Audentes Therapeutics, Inc. Common Stock 05070R104 25682392 1204615 SH OTR 0 1204615 0 ImmuneDesign Corp. Common Stock 45252L103 2870673 2208210 SH OTR 0 2208210 0 CRISPR Therapeutics AG Common Stock H17182108 103105530 3608874 SH OTR 0 3608874 0 OpGen, Inc. Common Stock 68373L109 132817 102167 SH OTR 0 102167 0 Veracyte, Inc. Common Stock 92337F107 45492060 3616221 SH OTR 0 3616221 0